Initiate Phase 2 study for Anemia of Inflammatory Bowel Disease
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 20 Oct 2025
- Due
- 31 Mar 2026
- Delivered
- Q1 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Anemia of Inflammatory Bowel Disease (IBD) – Phase 2 study initiation anticipated Q1 2026”
What we found
Evidence strength A What the grades mean
The company initiated the Phase 2 clinical trial for Anemia of Inflammatory Bowel Disease in the first quarter of 2026, meeting the stated deadline.
-
A Disc Medicine, Inc. 10-K filed 2026-02-26
“We initiated a Phase 2 clinical trial of DISC-0974 in patients with IBD and anemia in the first quarter of 2026.” ✓ confirmed on the page
Market reaction: the shares moved +0.4% against the S&P 500 over the three sessions around the disclosure (25 Feb 2026 to 2 Mar 2026). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- Phase 2 study for Anemia of IBD
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Disc Medicine, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-IRON-002207 · Corrections policy